Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 1376595, 14 pages
http://dx.doi.org/10.1155/2016/1376595
Review Article

The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk

1Department of Biomolecular Sciences, University of Urbino “Carlo Bo”, Urbino, Italy
2IRCCS Istituto Giannina Gaslini, Genova, Italy
3Department of Sensory Organs, University of Rome La Sapienza, Italy
4Gran Sasso National Laboratory, INFN, Assergi, L’Aquila, Italy

Received 1 September 2016; Accepted 8 November 2016

Academic Editor: Anil Shanker

Copyright © 2016 Sara Gabrielli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. W. Litman, J. P. Cannon, and L. J. Dishaw, “Reconstructing immune phylogeny: new perspectives,” Nature Reviews Immunology, vol. 5, no. 11, pp. 866–879, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. D. Hazenberg and H. Spits, “Human innate lymphoid cells,” Blood, vol. 124, no. 5, pp. 700–709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Lanier, “Shades of grey-the blurring view of innate and adaptive immunity,” Nature Reviews Immunology, vol. 13, no. 2, pp. 73–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Williams and M. J. Bevan, “Effector and memory CTL differentiation,” Annual Review of Immunology, vol. 25, pp. 171–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Luckey, D. Bhattacharya, A. W. Goldrath, I. L. Weissman, C. Benoist, and D. Mathis, “Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3304–3309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Wang, M. B. F. Werneck, B. G. Wilson et al., “TCR-dependent transformation of mature memory phenotype T cells in mice,” Journal of Clinical Investigation, vol. 121, no. 10, pp. 3834–3845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. K. Hwang, F. W. Alt, and L.-S. Yeap, “Related mechanisms of antibody somatic hypermutation and class switch recombination,” Microbiology Spectrum, vol. 3, no. 1, Article ID MDNA3-0037-2014, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kronenberg, “When less is more: T lymphocyte populations with restricted antigen receptor diversity,” Journal of Immunology, vol. 193, no. 3, pp. 975–976, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Holtmeier and D. Kabelitz, “γδ T cells link innate and adaptive immune responses,” Chemical Immunology and Allergy, vol. 86, pp. 151–183, 2005. View at Google Scholar · View at Scopus
  10. M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, “The biology of human natural killer-cell subsets,” Trends in Immunology, vol. 22, no. 11, pp. 633–640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. G. Freud and M. A. Caligiuri, “Human natural killer cell development,” Immunological Reviews, vol. 214, no. 1, pp. 56–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Zamai, G. Del Zotto, F. Buccella et al., “Cytotoxic functions and susceptibility to apoptosis of human CD56bright NK cells differentiated in vitro from CD34+ hematopoietic progenitors,” Cytometry Part A, vol. 81, no. 4, pp. 294–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Parrish-Novak, S. R. Dillon, A. Nelson et al., “Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function,” Nature, vol. 408, no. 6808, pp. 57–63, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zamai, L. Galeotti, G. Del Zotto, B. Canonico, P. Mirandola, and S. Papa, “Identification of a NCR+/NKG2D+/LFA-1(low)/CD94(-) immature human NK cell subset,” Cytometry A, vol. 75, no. 11, pp. 893–901, 2009. View at Google Scholar
  15. C. Fauriat, E. O. Long, H.-G. Ljunggren, and Y. T. Bryceson, “Regulation of human NK-cell cytokine and chemokine production by target cell recognition,” Blood, vol. 115, no. 11, pp. 2167–2176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. De Maria, F. Bozzano, C. Cantoni, and L. Moretta, “Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 2, pp. 728–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. G. Freud, B. Becknell, S. Roychowdhury et al., “A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells,” Immunity, vol. 22, no. 3, pp. 295–304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Vacca, C. Vitale, E. Montaldo et al., “CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 6, pp. 2402–2407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. K. Björkström, H. Ljunggren, and J. Michaëlsson, “Emerging insights into natural killer cells in human peripheral tissues,” Nature Reviews Immunology, vol. 16, no. 5, pp. 310–320, 2016. View at Publisher · View at Google Scholar
  20. A. Moretta, C. Bottino, M. Vitale et al., “Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis,” Annual Review of Immunology, vol. 19, pp. 197–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. V. M. Braud, D. S. J. Allan, C. A. O'Callaghan et al., “HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C,” Nature, vol. 391, no. 6669, pp. 795–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. G. Ljunggren and K. Karre, “In search of the ‘missing self’: MHC molecules and NK cell recognition,” Immunology Today, vol. 11, pp. 237–244, 1990. View at Google Scholar
  23. S. Kim, J. Poursine-Laurent, S. M. Truscott et al., “Licensing of natural killer cells by host major histocompatibility complex class I molecules,” Nature, vol. 436, no. 7051, pp. 709–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Anfossi, P. André, S. Guia et al., “Human NK Cell Education by Inhibitory Receptors for MHC Class I,” Immunity, vol. 25, no. 2, pp. 331–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Martin, X. Gao, J.-H. Lee et al., “Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS,” Nature Genetics, vol. 31, no. 4, pp. 429–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Martin, Y. Qi, X. Gao et al., “Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1,” Nature Genetics, vol. 39, no. 6, pp. 733–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. T. Bryceson, M. E. March, H.-G. Ljunggren, and E. O. Long, “Activation, coactivation, and costimulation of resting human natural killer cells,” Immunological Reviews, vol. 214, no. 1, pp. 73–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Zamai, C. Ponti, P. Mirandola et al., “NK cells and cancer,” The Journal of Immunology, vol. 178, no. 7, pp. 4011–4016, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Ruggeri, M. Capanni, M. Casucci et al., “Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation,” Blood, vol. 94, no. 1, pp. 333–339, 1999. View at Google Scholar · View at Scopus
  30. D. Pende, S. Marcenaro, M. Falco et al., “Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity,” Blood, vol. 113, no. 13, pp. 3119–3129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Velardi, L. Ruggeri, A. Mancusi, F. Aversa, and F. T. Christiansen, “Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia,” Current Opinion in Immunology, vol. 21, no. 5, pp. 525–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Moretta, D. Pende, F. Locatelli, and L. Moretta, “Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias,” Clinical and Experimental Immunology, vol. 157, no. 3, pp. 325–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Sánchez, M. O. Muench, M. G. Roncarolo, L. L. Lanier, and J. H. Phillips, “Identification of a common T/natural killer cell progenitor in human fetal thymus,” Journal of Experimental Medicine, vol. 180, no. 2, pp. 569–576, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Spits, L. L. Lanier, and J. H. Phillips, “Development of human T and natural killer cells,” Blood, vol. 85, no. 10, pp. 2654–2670, 1995. View at Google Scholar · View at Scopus
  35. G. Ferlazzo and C. Münz, “NK cell compartments and their activation by dendritic cells,” Journal of Immunology, vol. 172, no. 3, pp. 1333–1339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. G. W. Nelson, M. P. Martin, D. Gladman, J. Wade, J. Trowsdale, and M. Carrington, “Cutting edge: Heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis,” Journal of Immunology, vol. 173, no. 7, pp. 4273–4276, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Fadda, G. Borhis, P. Ahmed et al., “Peptide antagonism as a mechanism for NK cell activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 22, pp. 10160–10165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Arase, E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier, “Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors,” Science, vol. 296, no. 5571, pp. 1323–1326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. E. Hiby, J. J. Walker, K. M. O'Shaughnessy et al., “Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success,” Journal of Experimental Medicine, vol. 200, no. 8, pp. 957–965, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. E. Hiby, R. Apps, O. Chazara et al., “Maternal KIR in combination with paternal HLA-C2 regulate human birth weight,” Journal of Immunology, vol. 192, no. 11, pp. 5069–5073, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Moffett and F. Colucci, “Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction,” Immunological Reviews, vol. 267, no. 1, pp. 283–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. López-Botet, A. Angulo, and M. Gumá, “Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection,” Tissue Antigens, vol. 63, no. 3, pp. 195–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Campillo, J. A. Martínez-Escribano, M. R. Moya-Quiles et al., “Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients,” Clinical Cancer Research, vol. 12, no. 16, pp. 4822–4831, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Alter, S. Rihn, K. Walter et al., “HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection,” Journal of Virology, vol. 83, no. 13, pp. 6798–6805, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. V. Gorbachev and R. L. Fairchild, “Induction and regulation of T-cell priming for contact hypersensitivity,” Critical Reviews in Immunology, vol. 21, no. 5, pp. 451–472, 2001. View at Google Scholar · View at Scopus
  46. J. G. O'Leary, M. Goodarzi, D. L. Drayton, and U. H. von Andrian, “T cell- and B cell-independent adaptive immunity mediated by natural killer cells,” Nature Immunology, vol. 7, no. 5, pp. 507–516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Paust, H. S. Gill, B.-Z. Wang et al., “Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses,” Nature Immunology, vol. 11, no. 12, pp. 1127–1135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Peng, X. Jiang, Y. Chen et al., “Liver-resident NK cells confer adaptive immunity in skin-contact inflammation,” Journal of Clinical Investigation, vol. 123, no. 4, pp. 1444–1456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Zheng, R. Sun, H. Wei, and Z. Tian, “NK cells help induce Anti-Hepatitis B virus CD8+ T cell immunity in mice,” The Journal of Immunology, vol. 196, no. 10, pp. 4122–4131, 2016. View at Publisher · View at Google Scholar
  50. B. Gao, W.-I. Jeong, and Z. Tian, “Liver: an organ with predominant innate immunity,” Hepatology, vol. 47, no. 2, pp. 729–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Jiang, Y. Chen, H. Peng, and Z. Tian, “Memory NK cells: why do they reside in the liver?” Cellular and Molecular Immunology, vol. 10, no. 3, pp. 196–201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Paust and U. H. Von Andrian, “Natural killer cell memory,” Nature Immunology, vol. 12, no. 6, pp. 500–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. J. S. Orange, “Human natural killer cell deficiencies and susceptibility to infection,” Microbes and Infection, vol. 4, no. 15, pp. 1545–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. J. C. Sun, J. N. Beilke, and L. L. Lanier, “Adaptive immune features of natural killer cells,” Nature, vol. 457, no. 7233, pp. 557–561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. R. C. Smith, J. W. Heusel, I. K. Mehta et al., “Recognition of a virus-encoded ligand by a natural killer cell activation receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8826–8831, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. A. O. Dokun, S. Kim, H. R. C. Smith, H.-S. P. Kang, D. T. Chu, and W. M. Yokoyama, “Specific and nonspecific NK cell activation during virus infection,” Nature Immunology, vol. 2, no. 10, pp. 951–956, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Gumá, A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet, “Imprint of human cytomegalovirus infection on the NK cell receptor repertoire,” Blood, vol. 104, no. 12, pp. 3664–3671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Della Chiesa, M. Falco, L. Muccio, A. Bertaina, F. Locatelli, and A. Moretta, “Impact of HCMV infection on NK cell development and function after HSCT,” Frontiers in Immunology, vol. 4, article 458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Muntasell, A. Pupuleku, E. Cisneros et al., “Relationship of NKG2C copy number with the distribution of distinct cytomegalovirus-induced adaptive NK cell subsets,” The Journal of Immunology, vol. 196, no. 9, pp. 3818–3827, 2016. View at Publisher · View at Google Scholar
  60. H. Schlums, F. Cichocki, B. Tesi et al., “Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function,” Immunity, vol. 42, no. 3, pp. 443–456, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Costa-Garcia, A. Vera, M. Moraru, C. Vilches, M. López-Botet, and A. Muntasell, “Antibody- mediated response of NKG2Cbright NK cells against human cytomegalovirus,” The Journal of Immunology, vol. 194, pp. 2715–2724, 2015. View at Google Scholar
  62. A. Muntasell, M. López-Montañés, A. Vera et al., “NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus,” European Journal of Immunology, vol. 43, no. 12, pp. 3268–3278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. M. R. Goodier, M. J. White, A. Darboe et al., “Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions,” Blood, vol. 124, no. 14, pp. 2213–2222, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Oliviero, S. Varchetta, E. Paudice et al., “Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections,” Gastroenterology, vol. 137, no. 3, pp. 1151–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Béziat, O. Dalgard, T. Asselah et al., “CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients,” European Journal of Immunology, vol. 42, no. 2, pp. 447–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. D. W. Hendricks, H. H. Balfour Jr., S. K. Dunmire, D. O. Schmeling, K. A. Hogquist, and L. L. Lanier, “Cutting edge: NKG2ChiCD57+ NK cells respond specifically to acute infection with cytomegalovirus and not epstein-barr virus,” The Journal of Immunology, vol. 192, no. 10, pp. 4492–4496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. A. de Maria and L. Moretta, “NK cell function in HIV-1 infection,” Current HIV Research, vol. 6, no. 5, pp. 433–440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Lopez-Vergès, J. M. Milush, B. S. Schwartz et al., “Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 36, pp. 14725–14732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Foley, S. Cooley, M. R. Verneris et al., “Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen,” Journal of Immunology, vol. 189, no. 10, pp. 5082–5088, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. M. F. Abdul-Careem, A. J. Lee, E. A. Pek et al., “Genital HSV-2 infection induces short-term NK cell memory,” PLoS ONE, vol. 7, no. 3, Article ID e32821, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. N. K. Björkström, A. Svensson, K.-J. Malmberg, K. Eriksson, and H.-G. Ljunggren, “Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection,” PLoS ONE, vol. 6, no. 11, Article ID e27664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. G. O. Gillard, M. Bivas-Benita, A.-H. Hovav et al., “Thy1+ NK cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes,” PLoS Pathogens, vol. 7, no. 8, Article ID e1002141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. M. J. G. Van Helden, N. De Graaf, C. J. P. Boog, D. J. Topham, D. M. W. Zaiss, and A. J. A. M. Sijts, “The bone marrow functions as the central site of proliferation for long-lived NK cells,” Journal of Immunology, vol. 189, no. 5, pp. 2333–2337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. J. C. Sun, S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, and L. L. Lanier, “Proinflammatory cytokine signaling required for the generation of natural killer cell memory,” Journal of Experimental Medicine, vol. 209, no. 5, pp. 947–954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Cerwenka and L. L. Lanier, “Natural killer cell memory in infection, inflammation and cancer,” Nature Reviews Immunology, vol. 16, no. 2, pp. 112–123, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. A. M. Beaulieu, C. L. Zawislak, T. Nakayama, and J. C. Sun, “The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection,” Nature Immunology, vol. 15, no. 6, pp. 546–553, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. J. M. Karo, D. G. Schatz, and J. C. Sun, “The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells,” Cell, vol. 159, no. 1, pp. 94–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. M. A. Cooper, J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama, “Cytokine-induced memory-like natural killer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1915–1919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. M. P. Keppel, L. Yang, and M. A. Cooper, “Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation,” Journal of Immunology, vol. 190, no. 9, pp. 4754–4762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Romee, S. E. Schneider, J. W. Leong et al., “Cytokine activation induces human memory-like NK cells,” Blood, vol. 120, no. 24, pp. 4751–4760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Luetke-Eversloh, Q. Hammer, P. Durek et al., “Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells,” PLoS pathogens, vol. 10, no. 10, Article ID e1004441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. J. W. Leong, J. M. Chase, R. Romee et al., “Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells,” Biology of Blood and Marrow Transplantation, vol. 20, no. 4, pp. 463–473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Romee, M. Rosario, M. M. Berrien-Elliott et al., “Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia,” Science Translational Medicine, vol. 8, no. 357, Article ID 357ra123, 2016. View at Publisher · View at Google Scholar
  84. Y. Dou, B. Fu, R. Sun et al., “Influenza vaccine induces intracellular immune memory of human NK cells,” PLoS ONE, vol. 10, no. 3, Article ID e0121258, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Kleinnijenhuis, J. Quintin, F. Preijers et al., “Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17537–17542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. M. G. Netea, J. Quintin, and J. W. M. Van Der Meer, “Trained immunity: a memory for innate host defense,” Cell Host and Microbe, vol. 9, no. 5, pp. 355–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Kleinnijenhuis, J. Quintin, F. Preijers et al., “BCG-induced trained immunity in NK cells: role for non-specific protection to infection,” Clinical Immunology, vol. 155, no. 2, pp. 213–219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. R. Liu, F. Luo, X. Liu et al., “Biological response modifier in cancer immunotherapy,” Advances in Experimental Medicine and Biology, vol. 909, pp. 69–138, 2016. View at Google Scholar
  89. M.-F. Tsan, “Toll-like receptors, inflammation and cancer,” Seminars in Cancer Biology, vol. 16, no. 1, pp. 32–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Horowitz, R. H. Behrens, L. Okell, A. R. Fooks, and E. M. Riley, “NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination,” Journal of Immunology, vol. 185, no. 5, pp. 2808–2818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Jost, P. J. Tomezsko, K. Rands et al., “CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination,” Journal of Virology, vol. 88, no. 15, pp. 8349–8354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Nabekura, M. Kanaya, A. Shibuya, G. Fu, N. R. J. Gascoigne, and L. L. Lanier, “Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection,” Immunity, vol. 40, no. 2, pp. 225–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Sivori, C. Cantoni, S. Parolini et al., “IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors,” European Journal of Immunology, vol. 33, no. 12, pp. 3439–3447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Pène, J.-F. Gauchat, S. Lécart et al., “Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells,” The Journal of Immunology, vol. 172, no. 9, pp. 5154–5157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Bruhns, B. Iannascoli, P. England et al., “Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses,” Blood, vol. 113, no. 16, pp. 3716–3725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Zambello, M. Falco, M. Della Chiesa et al., “Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes,” Blood, vol. 102, no. 5, pp. 1797–1805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. R. Zambello, A. Teramo, G. Barilà, C. Gattazzo, and G. Semenzato, “Activating KIRs in chronic lymphoproliferative disorder of NK cells: protection from viruses and disease induction?” Frontiers in Immunology, vol. 5, article 00072, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Zambello, T. P. Loughran Jr., L. Trentin et al., “Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes,” Leukemia, vol. 9, no. 7, pp. 1207–1211, 1995. View at Google Scholar · View at Scopus
  99. E. Scquizzato, A. Teramo, M. Miorin et al., “Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes,” Leukemia, vol. 21, no. 5, pp. 1060–1069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Gattazzo, A. Teramo, M. Miorin et al., “Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes,” Haematologica, vol. 95, no. 10, pp. 1722–1729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Adib-Conquy, D. Scott-Algara, J.-M. Cavaillon, and F. Souza-Fonseca-Guimaraes, “TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals,” Immunology and Cell Biology, vol. 92, no. 3, pp. 256–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Sivori, M. Falco, M. Della Chiesa et al., “CpG and double-stranded RNA trigger human NK cells by toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 27, pp. 10116–10121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Martinez, X. Huang, and Y. Yang, “Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection,” PLoS Pathogens, vol. 6, no. 3, Article ID e1000811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. S. F. Martin, J. C. Dudda, E. Bachtanian et al., “Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity,” Journal of Experimental Medicine, vol. 205, no. 9, pp. 2151–2162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Nabekura and L. L. Lanier, “Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection,” The Journal of Experimental Medicine, vol. 213, no. 12, pp. 2745–2758, 2016. View at Publisher · View at Google Scholar
  106. F. Vély, V. Barlogis, B. Vallentin et al., “Evidence of innate lymphoid cell redundancy in humans,” Nature Immunology, vol. 17, no. 11, pp. 1291–1299, 2016. View at Publisher · View at Google Scholar
  107. A. Poggi and M. R. Zocchi, “NK cell autoreactivity and autoimmune diseases,” Frontiers in Immunology, vol. 5, article 27, 2014. View at Publisher · View at Google Scholar
  108. P. J. Norman, L. Abi-Rached, K. Gendzekhadze et al., “Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans,” Nature Genetics, vol. 39, no. 9, pp. 1092–1099, 2007. View at Publisher · View at Google Scholar · View at Scopus